Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Calderón Larrañaga, Amaia ^a   Poblador Plou, Beatriz ^a   López Cabñas, Anselmo ^a   Alcalá Nalvaiz, José Toms ^b   Abad Díez, José María ^a,c   Bordonaba Bosque, Daniel ^a   Prados Torres, Alexandra ^a  

^a INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c Government of Aragon   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951942017     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-244     Document Type: Article

References (40)

1. Prescription drug spending: contribution to health care spending and cost containment strategies. PA Rivers NG Hall J Frimpong, J Health Care Finance 2006 32 8 19 18975728
2. Instituto Nacional de la Salud, Subdireccián General de Coordinacián Administrativa, Memoria 2000. Madrid 2001
3. Sources, uses, strengths and limitations of data collected in primary care in England. A Majeed, Health Stat Q 2004 21 5 14 15615148
4. Threads and yarns: weaving the tapestry of comorbidity. B Starfield, Ann Fam Med 2006 4 101 103 10.1370/afm.524 16569711
5. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes. LA Petersen K Pietz LD Woodard M Byrne, Med Care 2005 43 61 67 15626935
6. Development and application of a population-oriented measure of ambulatory care case-mix. JP Weiner BH Starfield DM Steinwachs LM Mumford, Med Care 1991 29 452 472 10.1097/00005650-199105000-00006 1902278
7. Ambulatory care groups: a categorization of diagnoses for research and management. B Starfield J Weiner L Mumford D Steinwachs, Health Serv Res 1991 26 53 74 1901841
8. [Classification systems in case-mix groups in ambulatory care. Perspectives for our primary health care]. S Juncosa E Carrillo B Bolibar A Prados J Gervas, Aten Primaria 1996 17 76 82 8742149
9. Ambulatory care groupings: when, how, and the impact on managed care. DS Kolb SB Clay, J Ambul Care Manage 1994 17 1 29 38 10131098
10. FR Hampel, Robust Statistics: The Approach Based on Influence Functions New York: Wiley 1986
11. H Lamberts M Wood, ICPC: International Classification of Primary Care Oxford: Oxford University Press 1987
12. Ministry of Health and Consumption, International Classification of Diseases, Ninth Revision, Clinical Modification. Madrid 1999
13. The Johns Hopkins ACG System, Version 8.1. Reference Manual. Baltimore 2006
14. Detection of outliers. A Hadi A Rahmatullah M Werner, WIREs Comp Stati 2009 1 57 70 10.1002/wics.6
15. JW Tukey, Exploratory data analysis Reading, MA: Addison-Wesley 1977
16. D Hoaglin F Mosteller J Tukey, Understanding robust and exploratory data analysis New York: Wiley 1983
17. An adjusted boxplot for skewed distributions. M Hubert E Vandervieren, Comput Stat Data Anal 2008 12 5186 5201 10.1016/j.csda.2007.11.008
18. The maximum size of standardized and internally studentized residuals in regression analysis. G Gray W Woodall, Am Stat 1994 2 111 113 10.2307/2684258
19. DA Belsley E Kuh RE Welsh, Regression diagnostics: identifying influential data and sources of collinearity New York: Wiley 1980
20. D Kleinbaum L Kupper K Muller A Nizam, Applied Regression Analysis and other Multivariable Methods Pacific Grove CA: Duxbury Press 3 1998
21. Estimation of relationships for limited dependent variables. J Tobin, Econometrica 1958 26 24
22. Una revisián de modelos econométricos aplicados al anlsis de demanda y utilizacián de servicios sanitarios. A Clavero ML Gonzlez, Hacienda Pblica Espãola 2005 173 129 162
23. European Healthcare Policies for Controlling Drug Expenditure. S Ess S Schneeweiss T Szucs, Pharmacoeconomics 2003 2 89 103 10.2165/00019053-200321020- 00002 (Pubitemid 36127005)
24. Printed educational materials: effects on professional practice and health care outcomes. A Farmer F Légaré L Turcot J Grimshaw E Arvey J McGowan F Wolf, Cochrane Database Syst Rev 2008 3 CD004398
25. Guided care for multimorbid older adults. CM Boyd C Boult E Shadmi B Leff R Brager L Dunbar JL Wolff S Wegener, Gerontologist 2007 47 697 704 17989412
26. The Effects of a Disease Management Program on Self-Reported Health Behaviors and Health Outcomes: Evidence From the "Florida: A Healthy State (FAHS)" Medicaid Program. DE Morisky GF Kominski AA Afifi JB Kotlerman, Health Educ Behav 2009 36 3 505 17 10.1177/1090198107311279 18292218
27. Analysis of cost outliers within APR-DRGs in a Belgian general hospital: two complementary approaches. M Pirson M Dramaix P Leclercq T Jackson, Health Policy 2006 1 13 25 10.1016/j.healthpol.2005.04.008 (Pubitemid 43247314)
28. Relevance of outlier cases in case mix systems and evaluation of trimming methods. F Cots D Elvira X Castells M Saez, Health Care Manag Sci 2003 6 27 35 10.1023/A:1021908220013 12638924
29. [Explanatory variables of avoidable cost produced by not prescribing a cheaper equivalent drug]. F Caamão A Figueiras E Lado J Gestal-Otero, Gac Sanit 2001 6 513 518
30. A qualitative study of GPs' and PCO stakeholders' views on the importance and influence of cost on prescribing. HWT Prosser, Soc Sci Med 2005 60 1335 1346 10.1016/j.socscimed.2004.07.013 15626528
31. A study of factors associated with cost and variation in prescribing among GPs. P Carthy I Harvey R Brawn C Watkins, Fam Pract 2000 1 36 41 10.1093/fampra/17.1.36
32. [Prescription of drugs in family medicine: on the trail of efficiency]. J Lopez-Picazo J Sanchez V Rausell J Sanz F Sanchez E Salas, Aten Primaria 2004 4 178 185 10.1157/13065827 (Pubitemid 39456547)
33. [Factors affecting drug expenditure in the primary care centres in a health area]. M Azpiazu L García, Aten Primaria 2002 2 84 89
34. Risk adjustment using administrative data-based and survey-derived methods for explaining physician utilization. LM Sibley R Moineddin MM Agha RH Glazier, Med Care 2010 48 2 175 182 10.1097/MLR.0b013e3181c16102 19927013
35. [Validating the Adjusted Clinical Groups [ACG] case-mix system in a Spanish population setting: a multicenter study]. A Sicras-Mainar R Navarro-Artieda, Gac Sanit 2009 23 3 228 231 10.1016/j.gaceta.2008.04.005 19268402
36. Validation of ACG Case-mix for equitable resource allocation in Swedish primary health care. A Zielinski M Kronogard H Lenhoff A Halling, BMC Public Health 2009 9 347 10.1186/1471-2458-9-347 19765286
37. An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan. HY Chang JP Weiner, BMC Med 2010 8 7 10.1186/1741-7015-8-7 20082689
38. Pharmaceutical expenditures as a correlate of population health in industrialized nations. L Liu RR Cline SW Schondelmeyer JC Schommer, Ann Pharmacother 2008 42 368 374 10.1345/aph.1K352 18272699
39. Using risk-adjustment models to identify high-cost risks. RT Meenan MJ Goodman PA Fishman MC Hornbrook MC O'Keeffe-Rosetti DJ Bachman, Med Care 2003 41 1301 1312 10.1097/01.MLR.0000094480.13057.75 14583693
40. The importance of comorbidity in analysing patient costs in Swedish primary care. SG Engstrom L Carlsson CJ Ostgren GH Nilsson LA Borgquist, BMC Public Health 2006 6 36 10.1186/1471-2458-6-36 16483369